• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Carfilzomib and dexamethasone (Kd) vs bortezomib and dexamethasone (Vd) in patients with relapsed mu

Carfilzomib and dexamethasone (Kd) vs bortezomib and dexamethasone (Vd) in patients with relapsed mu

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：wade68
【摘 要】
：
Objective: ENDEAVOR (NCT01568866) is comparing Kd with Vd in patients with RMM.The primary endpoint is PFS.Secondary endpoints include OS, ORR, peripheral neuropathy (PN) rate, and safety.
【作 者】
：
Meletios Dimopoulos Philippe Moreau Antonio Palumbo Douglas Joshua Ludek Pour Roman Hájek Thierry Facon Heinz Ludwig Albert Oriol Laura Rosi(n)ol Jan Straub Aleksandr Suvorov Elena Rimashevskaya Katja 
【机 构】
：
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Ath
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
【关键词】
：
Carfilzomib Bortezomib Multiple myeloma 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective: ENDEAVOR (NCT01568866) is comparing Kd with Vd in patients with RMM.The primary endpoint is PFS.Secondary endpoints include OS, ORR, peripheral neuropathy (PN) rate, and safety.
其他文献
梭形细胞血管瘤诊疗进展及治疗体会
梭形细胞血管瘤是是一种少见位于肢体末端的单发或多发皮下良性血管增生性病变，病理上以巯松的血管性结构和实质性梭形细胞结构为特点。多见于远侧肢端皮下，尤其手部、足部，患者一般无自觉症状，个别有疼痛或局部压痛的主诉。当前治疗梭形细胞血管瘤的主要方法是手术切除，但手术复发率高达50％。由于梭形细胞血管瘤有丰富的血管腔隙，因此我们尝试性对2例左手多发的梭形细胞血管瘤进行无水乙醇及博来霉素局部栓塞硬化治疗，共
会议
A Randomized, Open-label, Multi-center Phase Ⅱ Study to Compare Bevacizumab plus Sorafenib Versus So
目的： There is no standard treatment in patients with renal cell carcinoma that was previously treated with VEGF-targeted therapies and mTOR inhibitors.From the Gold study, Sorafenib might be an option
会议
Renal
Immunotherapy with patient-specific antigens selection reduced the metastasis of acervical cancer pa
Objective: Cervical cancer is the second most common Gynecologic malignant tumor and frequently occurs in patients with human papilloma virus (HPV)infection.Effective treatment for cervical cancer (in
会议
MASCTCervical cancerTumor antigensspecific T cell
CRABP2 gene reverse platinum resistance via Fas signaling pathway in epithelial ovarian cancer
Objective: Platinum-resistant play an important role of poor prognosis in ovarian cancer.Cellular retinoic acid-binding protein 2(CRABP2) were considered the potential upstream molecules for inhibitin
会议
Platinum resistantEpithelial ovarian cancer
Irreversible electroporation mediated HPV18 E6 targeted shRNA suppressed cervical cancer growth in v
Objective: To verify the feasibility of using irreversible electroporation (IRE) to mediate HPV18 E6 shRNA plasmid into cervical cancer cell HeLa in vitro and in vivo, and their co-effect on cell and
会议
Irreversible electroporationshRNA plasmid
The clinical observation of Bevacizumab combined chemotherapy to treat persistent and/or recurrent u
Objective: To observe the therapeutic effect of Bevacizumab (BEV) combined chemotherapy to treat persistent and/or recurrent uterine sarcomas.Method: From May 2006 to May 2014 clinical data from 4 per
会议
Uterine sarcomasBevacizumabCombined chemotherapy
不可逆性电穿孔对宫颈癌残留肿瘤生物学行为的影响
目的：以不可逆性电穿孔(Irreversible electroporation；IRE)不完全消融人宫颈癌荷瘤裸鼠模型，研究残留肿瘤的生物学行为变化，为进一步优化IRE肿瘤治疗策提供理论依据。
会议
不可逆性电穿孔宫颈癌小动物活体成像
无花果水提取液抗宫颈癌细胞增殖作用的初步研究
目的：探讨无花果水提取液(fig extract,FE)对宫颈癌细胞(Hella细胞)增殖的影响及其机制。方法：MTT法检测不同浓度无花果提取液对宫颈癌细胞增殖的影响,荧光显微镜观察细胞形态改变,流式细胞术检测细胞凋亡变化。
会议
无花果宫颈癌细胞细胞凋亡
RNAi介导的WFDC2基因沉默在人卵巢浆液性上皮癌发展中的作用及其机制的初步研究
目的：1.构建WFDC2基因稳定低表达的人浆液性卵巢癌细胞株SKOV3,体外检测WFDC2基因沉默对肿瘤细胞增殖、凋亡、侵袭和迁移能力的影响.2.构建裸鼠皮下移植瘤模型,观察肿瘤生长、转移特点的变化.
会议
人附睾蛋白4卵巢癌
Weekly Carfilzomib With Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma: Upd
Objective: Carfilzomib (K) is a selective proteasome inhibitor that is approved in the United States for the treatment of relapsed and refractory multiple myeloma.
会议
CarfilzomibMultiple myeloma